Changes in Corneal Higher-Order Aberrations and Ocular Biometric Measurements after Phacoemulsification Combined with Goniosynechialysis in Primary Angle Closure/Glaucoma Patients

Table 1

Patients’ baseline demographics.

	AL ≤ 22.5 mm	22.5 < AL ≤ 24.5 mm
Eyes (n)	48	48	—
Male/female	4/44	16/32	0.003
Mean age (y)	64.48 ± 6.58	67.38 ± 8.10	0.058
Nuclear grade of cataract	2–4	2–4	—
Mean AL (mm)	21.82 ± 0.53	23.26 ± 0.52	<0.01
K value (D)	45.76 ± 1.46	43.49 ± 0.98	<0.01
Astigmatism (D)	−0.77 ± 0,65	−0.64 ± 0.40	0.228
ACD (mm)	2.04 ± 0.28	2.09 ± 0.37	0.536
SE (D)	0.52 ± 1.65	−0.08 ± 2.18	0.201
IOP (mmHg)	23.42 ± 9.39	22.06 ± 7.89	0.673
BCVA	0.41 ± 0.48	0.40 ± 0.34	0.251
Predicted SE (D)	−0.27 ± 0.28	−0.38 ± 0.37	0.600
Number of antiglaucoma medications	2.60 ± 1.01	2.85 ± 0.80	0.238

was considered statistically significant. ACD: anterior chamber depth; AL: axial length; D: diopter; IOP: intraocular pressure; SE: spherical equivalent; BCVA: best-corrected visual acuity.